Please Wait.....
Report
Canine Atopic Dermatitis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
Market Report I 2026-03-11 I 142 Pages I Global Market Insights
The Global Canine Atopic Dermatitis Market was valued at USD 1.5 billion in 2025 and is estimated to grow at a CAGR of 9.2% to reach USD 3.6 billion by 2035.
The market growth is driven by the rising prevalence of atopic dermatitis in dogs and a growing focus on companion animal healthcare. Increasing awareness among pet owners about their pets' well-being is fueling demand for advanced veterinary dermatology therapies. The market is also benefiting from innovations in veterinary medications, as pet owners and veterinarians seek safe, effective, and targeted treatment options for chronic skin conditions. With the expansion of veterinary infrastructure and specialized clinics in both developed and emerging regions, more dogs are receiving proper diagnosis and treatment. Rising disposable incomes in emerging markets further encourage investments in pet healthcare. As awareness of the importance of preventative and ongoing dermatological care spreads, the canine atopic dermatitis market is witnessing steady and sustained growth across geographies.
Canine atopic dermatitis is a chronic, genetically influenced inflammatory skin disorder caused by hypersensitivity to environmental allergens like dust mites, pollen, mold, or specific foods. The condition triggers an exaggerated immune response, resulting in persistent itching, redness, and recurrent skin and ear infections. The development of innovative veterinary treatments such as monoclonal antibodies and oral therapies has transformed disease management. Monoclonal antibodies offer targeted relief from pruritus and inflammation, while oral therapies provide convenience and efficacy for long-term treatment. Rising knowledge of companion animal health, especially in emerging economies, is driving higher adoption rates and increased investment in veterinary therapeutics.
The glucocorticoids segment generated USD 511.6 million in 2025. These medications, including prednisone and dexamethasone, are highly effective in rapidly alleviating inflammation and itching, making them the preferred choice for severe or acute flare-ups. Their affordability compared to newer targeted therapies supports their continued adoption, particularly in regions with limited access to advanced veterinary care or low pet insurance penetration.
The oral administration segment held a 47.3% share in 2025. Oral medications like oclacitinib and glucocorticoids are favored by pet owners due to ease of use, which improves compliance and ensures consistent treatment. These therapies deliver fast relief for pruritus and inflammation and are effective for both acute and chronic conditions. Targeted oral treatments enhance efficacy by specifically modulating inflammatory pathways, reinforcing their popularity in veterinary dermatology practices.
North America Canine Atopic Dermatitis Market held 41% share and is expected to grow at a 9% CAGR through 2035. Strong veterinary infrastructure, access to innovative dermatology treatments, and widespread adoption of advanced therapies such as monoclonal antibodies are supporting regional market growth. Pet owners' increasing willingness to invest in specialized care and the prevalence of chronic dermatological conditions among dogs further strengthen North America's market leadership.
Key players operating in the Global Canine Atopic Dermatitis Market include AB Science, Boehringer Ingelheim, Ceva, Dechra Veterinary Products, Elanco Animal Health, Kindred Biosciences, Nextmune, Phibro Animal Health Corporation, Toray Industries, Vetoquinol, Virbac, and Zoetis. Companies in the Global Canine Atopic Dermatitis Market are focusing on R&D to develop innovative therapies, including monoclonal antibodies, targeted oral medications, and combination treatments. They are investing in clinical trials to demonstrate safety and efficacy while expanding product portfolios to address different severity levels and breeds. Strategic collaborations with veterinary clinics and distribution partners, along with educational initiatives to increase awareness among pet owners and veterinarians, are central to expanding market reach. Firms are also entering emerging markets and leveraging digital marketing to increase product adoption and improve brand visibility, enhancing their competitive position.
Report Content
Chapter 1 Research Methodology
1.1 Market scope and definition
1.2 Research approach
1.3 Quality commitments
1.3.1 GMI AI policy and data integrity commitment
1.3.1.1 Source consistency protocol
1.4 Research trail and confidence scoring
1.4.1 Research trail components
1.4.2 Scoring components
1.5 Data collection
1.5.1 Partial list of primary sources
1.6 Data mining sources
1.6.1 Paid sources
1.6.1.1 Sources, by region
1.7 Base estimates and calculations
1.7.1 Revenue share analysis
1.7.2 Base year calculation
1.8 Forecast model
1.9 Research transparency addendum
1.9.1 Source attribution framework
1.9.2 Quality assurance metrics
1.9.3 Our commitment to trust
Chapter 2 Executive Summary
2.1 Industry 360 synopsis
2.2 Key market trends
2.2.1 Regional trends
2.2.2 Product trends
2.2.3 Route of administration trends
2.2.4 Distribution channel trends
2.3 CXO perspectives: Strategic imperatives
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising pet ownership and humanization of pets
3.2.1.2 Increased awareness of skin disorders and advanced treatment options
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effect of few medications
3.2.2.2 Off-label use of human drugs
3.2.3 Market opportunities
3.2.3.1 Growing demand and utilization of combination therapies
3.2.3.2 Development of pediatric ulcerative colitis treatment
3.3 Growth potential analysis
3.4 Regulatory landscape (Driven by primary research)
3.4.1 North America
3.4.1.1 U.S.
3.4.1.2 Canada
3.4.2 Europe
3.4.3 Asia Pacific
3.5 Pricing analysis (Driven by primary research)
3.6 Pipeline and clinical trials landscape
3.7 Future market trends
3.8 Impact of AI and generative AI on the market
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2025
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
4.6.1 Merger and acquisition
4.6.2 Partnership and collaboration
4.6.3 New product launches
4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)
5.1 Key trends
5.2 Glucocorticoids
5.3 Antihistamines
5.4 Immunosuppressants
5.5 MAbs
5.6 Other products
Chapter 6 Market Estimates and Forecast, By Route of Administration, 2022 - 2035 ($ Mn)
6.1 Key trends
6.2 Oral
6.3 Topical
6.4 Injectable
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2022 - 2035 ($ Mn)
7.1 Key trends
7.2 Retail pharmacies
7.3 Veterinary hospital pharmacies
7.4 Online pharmacies
Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 AB Science
9.2 Boehringer Ingelheim
9.3 Ceva
9.4 Dechra Veterinary Products
9.5 Elanco
9.6 Kindred Biosciences
9.7 Nextmune (Vimian)
9.8 Phibro Animal Health Corporation
9.9 Toray Industries
9.10 Vetoquinol
9.11 Virbac
9.12 Zoetis
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security